Kinfo
Enovis Corporation logo

Enovis Corporation

CFXNYSEHealthcare·US · USD
$27.16
-1.46 (-5.10%)
Prices as of November 6, 2026 · live

Price

Key statistics

Valuation
Market cap1.46B USD
Enterprise value3.02B USD
Trailing P/E28.55
Forward P/E14.52
PEG ratio-0.86
Price / sales0.38
Price / book-14.64
Profitability
Gross margin42.04%
Operating margin0.00%
Profit margin41.87%
Return on assets2.32%
Return on equity97.94%
Income (TTM)
Revenue3.85B USD
Gross profit1.61B USD
EBITDA557.14M USD
Net income71.66M USD
Diluted EPS$0.00
Rev. growth (YoY)0.01%
Balance sheet
Total cash0.00 USD
Total debt2.25B USD
Debt / equity50.39
Current ratio2.19
Book value / share$0.83
Cash flow (TTM)
Operating cash flow340.01M USD
Levered free cash flow2.50B USD
Shares & price
Shares outstanding53.78M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$32.41
52-week low$16.70
Earnings (EPS)
DateEst.ActualSurprise2022-02-221.721.77+2.91%2021-11-041.601.62+1.25%2021-07-281.591.68+5.66%2021-04-291.191.32+10.92%2021-02-181.491.53+2.68%
About Enovis Corporation

Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. Enovis Corporation designs, manufactures, and distributes medical devices and services used across the patient care continuum, including injury prevention, rehabilitation, pain management, physical therapy, and reconstructive surgery. Its product portfolio includes orthopedic braces and supports, recovery and rehabilitation technologies, joint replacement implants, and surgical enabling tools that support hip, knee, shoulder, elbow, foot, ankle, and other extremity procedures. The company serves healthcare professionals and patients through two main business segments, Prevention & Recovery and Reconstructive, reflecting its role in both non-surgical treatment and surgical care. Enovis Corporation operates in the orthopedic and broader medical device markets, where it provides solutions intended to improve mobility, restore function, and support clinical workflows across hospitals, outpatient settings, and other care environments.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Damien McDonald
Employees
7,367
Headquarters
Wilmington, DE, United States

Frequently asked questions about Enovis Corporation